Join
Live feed
·
PRReleasevia Quantisnow
Kymera Therapeutics Inc. logo

Kymera Therapeutics Announces Closing of Upsized $225 Million Public Offering and Full Exercise of Underwriters' Option to Purchase Additional Shares

ByQuantisnow·Wall Street's wire, on your screen.
KYMR· Kymera Therapeutics Inc.
Health Care

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track KYMR (Kymera Therapeutics Inc.) and more on Quantisnow.